BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 26, 2018
View Archived Issues
FDA grants orphan drug designation to GDC-0084 for glioblastoma multiforme
Read More
EC first to approve Crysvita for treatment of X-linked hypophosphatemia
Read More
CHMP adopts positive opinion for Lynparza tablets in platinum-sensitive relapsed ovarian cancer
Read More
Orencia approved for active polyarticular JIA in Japan
Read More
First patient enrolled in phase II study of defibrotide for acute GvHD
Read More
Provectus updates progress of PV-10 GI cancer program
Read More
Prevymis launched in Germany
Read More
EMA committee recommends against expanding use of Sutent in adults at high risk of recurrent RCC
Read More
FDA accepts Mallinckrodt's NDA for stannsoporfin
Read More
University of South Florida patents reelin compounds for neurodegeneration
Read More
EMA committee hands down negative opinion on Puma's neratinib
Read More
Takeda divulges new ROR-gammaT modulators for cancer
Read More
Bellicum Pharmaceuticals gives update on FDA clinical hold on BPX-501
Read More
InnoCare Pharma identifies novel FGFR inhibitors
Read More
Toray Industries discovers microRNA-4454-targeting antisense polynucloetides
Read More
New mouse model points to TGF-beta signaling in metastatic colorectal cancers
Read More
Xgeva recommended for E.U. approval to prevent skeletal-related events in multiple myeloma
Read More
Novel GCN2 inhibitors presented by Takeda
Read More
FDA approves Apadaz for short-term management of acute pain
Read More
EMA committee hands down positive opinion for Kineret in Still's disease
Read More
EMA committee recommends approval of Mylotarg and Bosulif in E.U.
Read More
NOP agonist AT-312 can reduce alcohol reward
Read More
University of Liverpool leads project to develop Zika virus vaccine suitable for use in pregnancy
Read More
Researchers detail development and antitumor activity of MK-8353 in patients with solid tumors
Read More
Amglidia recommended for E.U. approval for neonatal diabetes
Read More
BioCryst's Alpivab recommended for approval in E.U. for uncomplicated influenza
Read More
ARS-1620 is a potent and selective new compound targeting p.G12C KRAS mutant cancers
Read More
EMA committee recommends change to marketing authorization terms for Feraccru
Read More
FDA agrees to waive pediatric trials for Luye's LY-03004
Read More
We want your opinion - complete our user survey
Read More